Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index; 28 of the 40 sources its claims cite were checked for support.

Legacy lessons from the COVID-19 era to improve trial participation and retention: Views from trial participants, PPIE contributors and trial staff across the NIHR portfolio

Open access
Leggett, Heather, Vinall-Collier, Karen, Csikar, Julia, Barber, Sophy, Carr, Rachel, Bhatti, Amrit, Pavitt, Sue · 2024 · PLoS ONE

Abstract

The Covid-19 pandemic had a profound effect on the delivery of healthcare research. This study explores the engagement experiences of trial participants’, PPIE contributors’ and trial staff during the Covid-19 pandemic and towards recovery and restoring a diverse and balanced UK clinical trials portfolio including oral and dental health trials.

Overview

CoChat Summary

## TL;DR

This qualitative NIHR study interviewed PPIE contributors, trial participants, and trial staff across multiple specialties to understand what helped or hindered trial engagement during COVID-19. It found three main facilitators: continued contact and communication, a balanced use of remote methods, and clear information that helped people feel safe and informed.

## Key findings

  • The study recruited 106 participants: 45 PPIE contributors, 27 trial participants, and 34 trial staff members.
  • Thematic analysis produced 3 themes: ensuring continued contact, a balanced move to remote consultations, and the importance of feeling fully informed / safe and informed of new rules.
  • Continued contact supported engagement and retention: telephone, emails, texts, and postal letters were used, with telephone described as a key facilitator; regular updates helped participants feel more engaged and less “left in the dark.”
  • Remote consultations were often valued for convenience, keeping participants in the trial, and enabling wider UK recruitment, but barriers included loss of personal contact, communication limits, missed diagnoses, and technical problems, especially for older or disadvantaged participants.
  • Feeling informed and safe mattered: participants wanted clear, detailed information about what would happen, Covid-19 precautions, and site rules; safety measures such as PPE, distancing, one-way systems, cleanliness, and clear signage increased confidence.

## Methods

  • Design: Qualitative study using semi-structured interviews and focus groups with PPIE contributors, trial participants, and trial staff from NIHR-funded/CRN portfolio studies across the UK.
  • Sample/data: Participants were recruited from multiple specialties including Cancer, Oral and Dental Health, Musculoskeletal Disorders, Cardiovascular Disease, Neurological Disorders, Primary Care, and conditions associated with susceptibility to Covid-19 (Diabetes, Stroke, Respiratory Disorders). Data collection ran from November 2020 to July 2021.
  • Analysis: Interviews/focus groups were recorded over Zoom, transcribed, and analysed using codebook thematic analysis in NVivo v12; 4 transcripts were double-coded during framework development.

## Limitations

  • The paper states there was not equal representation across participant groups/specialties, and some specialties had larger participant numbers than others.
  • The authors say they were unable to achieve diversity with regards to ethnicity despite aiming for maximum variation.
  • The text says all interviews and focus groups were conducted online, which likely limited participation to people familiar with video conferencing and may not represent people less comfortable with online methods.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0296343

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig 1 The NIHR clinical research network and UK research infrastructure and its’ response to restarting the NIHR portfolio of studies during COVID-19.
Fig 1 The NIHR clinical research network and UK research infrastructure and its’ response to restarting the NIHR portfolio of studies during COVID-19.CC BY · PubMed Central
Fig 2 Geographical distribution of trial participants and PPIE contributors.
Fig 2 Geographical distribution of trial participants and PPIE contributors.CC BY · PubMed Central

Verification

Claims the paper makes

24 Valid · 2 Not valid · 13 Not checked · 94 Own results and interpretations

39 more claims

Create a free account to see all 133 claims and to verify the 1 reference still open.

See all claims — free account
  • Probably not a substantial claim. 65
  • It may state two separate claims as one. 49

Create a free account to see these claims.

Citations

Cites

Show all 27 references

Research works printed but not linked: 4

  1. 2020, NIHR shares first update on implementation of the Restart Framework
  2. National Institute for Health Research, DHSC issues guidance on the impact of COVID-19 on research funded or supported by NIHR 16/03/21
  3. 2022, Timeline of UK government coronavirus lockdowns and measures, March 2020 to December 2021, Institute for Government analysis
  4. 2021, NIHR issues final update on implementation of the Restart Framework

Cited by

See all 4

Metadata

Authors
Leggett, H., Vinall-Collier, K., Csikar, J., Barber, S., Carr, R., Bhatti, A., & Pavitt, S.
Affiliations
  • University of York (GB)
  • University of Leeds (GB)
Corresponding author
Leggett, Heather
Venue
PLoS ONE
Published
2024-02-21
Volume
19
Issue
2
Pages
e0296343
ISSN
1932-6203 (ISSN-L)
OpenAlex
W4391993616
Cited by
4
References
27
Citations by year
2026: 1 · 2025: 1 · 2024: 2
FWCI
1.65
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
NIHR Yorkshire and Humber strategic funding (2021-014-HEICOVID & Us - VACCINE & Restart.)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
  • Health Sciences › Health Professions › General Health Professions › Mental Health and Patient Involvement
  • Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
Keywords
COVID-19 pandemic, clinical trial participation, trial retention, patient and public involvement, trial participants, teleconsultation, participant communication, informed consent, research disruption, pandemic preparedness, NIHR
MeSH terms
COVID-19, Aged, Clinical Trials as Topic, Communication, Humans, Focus Groups, Trust, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Legacy lessons from the COVID-19 era to improve trial participation and retention: Views from trial participants, PPIE contributors and trial staff across the NIHR portfolio. https://app.cochat.ai/papers/10.1371/journal.pone.0296343
The paper
Leggett, H., Vinall-Collier, K., Csikar, J., Barber, S., Carr, R., Bhatti, A., & Pavitt, S. (2024). Legacy lessons from the COVID-19 era to improve trial participation and retention: Views from trial participants, PPIE contributors and trial staff across the NIHR portfolio. PLoS ONE. https://doi.org/10.1371/journal.pone.0296343

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.